封面
市場調查報告書
商品編碼
1522269

2024 年神經血管栓塞裝置全球市場報告

Neurovascular Embolization Devices Global Market Report 2024

出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

神經血管栓塞器械市場規模預計在未來幾年將強勁成長,預計到 2028 年將以 6.9% 的年複合成長率(CAGR)成長至 16 億美元。預測期內的預期成長是由於新興市場的可用性增加、注重以患者為中心的護理、對神經血管疾病的認知提高、成像技術的進步以及研發投資的增加。預測期內的主要趨勢包括個人化治療策略、將人工智慧引入治療計劃、引入下一代栓塞材料、向門診和門診護理的轉變以及先進栓塞技術的創新。

出血發生率的增加預計將推動神經血管栓塞器械市場的發展。出血是指因皮膚或黏膜破裂而在體內或體外發生的異常、不受控制的出血。人口老化、高血壓的增加和抗凝血劑使用的增加導致出血的發生。神經血管栓塞裝置透過阻斷異常血管以限制出血並避免對大腦的進一步損傷,在出血性中風的治療中發揮重要作用。例如,倫敦國王學院最近進行的一項研究發現,到 2050 年,英國70 歲至 95 歲人群中腦出血(一種特定類型的出血)的病例和死亡人數預計將增加 59.4%。因此,腦出血盛行率的上升正在推動神經血管栓塞設備市場的成長。

神經血管栓塞器械領域的主要企業正致力於開發屏蔽技術等技術先進的產品,以解決腦動脈瘤問題並增強其市場競爭力。屏蔽技術是指旨在提高腦動脈瘤治療設備的有效性和安全性,同時也有助於其整體耐用性和壽命的先進特性。例如,總部位於愛爾蘭的醫療保健技術公司 Medtronic PLC 於 2022 年 6 月在印度推出了第四代分流器 Pipeline Vantage with Shield Technology。該設備包括增強的設計功能,以提高血管內手術過程中的易用性和可靠性。透過促進血管內膜中的細胞增殖,它提供了一個支架,有助於動脈瘤的微創治療,降低破裂風險並改善患者預後。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 市場促進和限制因素
    • 市場促進因素
    • 市場限制因素
  • 2018-2023 年市場規模表現與成長
  • 市場規模預測與成長,2023-2028,2033F

第6章 市場細分

  • 全球神經血管栓塞裝置市場:依產品分類的績效與預測,2018-2023、2023-2028F、2033F
  • 栓塞彈簧圈
  • 液體栓塞系統
  • 分流器支架
  • 動脈瘤夾
  • 其他
  • 全球神經血管栓塞裝置市場:依治療方法分類的表現與預測,2018-2023、2023-2028F、2033F
  • 缺血性中風解決方案
  • 出血性中風解決方案
  • 全球神經血管栓塞器材市場:依適應症分類的表現與預測,2018-2023、2023-2028F、2033F
  • 腦動脈瘤
  • 動靜脈畸形
  • 其他
  • 全球神經血管栓塞設備市場:最終用戶的表現和預測,2018-2023、2023-2028F、2033F
  • 醫院
  • 門診手術中心
  • 其他

第 7 章 區域/國家分析

  • 全球神經血管栓塞設備市場:按地區分類的表現和預測,2018-2023、2023-2028F、2033F
  • 全球神經血管栓塞裝置市場:按國家分類的表現和預測,2018-2023、2023-2028F、2033F

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 神經血管栓塞器材市場:競爭格局
  • 神經血管栓塞裝置市場:公司簡介
    • Johnson & Johnson
    • Abbott Laboratories
    • Medtronic plc
    • Heraeus Holding
    • Stryker Corporation

第31章 其他重大及創新企業

  • Boston Scientific Corporation
  • Kaneka Corporation
  • Terumo Corporation
  • B Braun Melsungen AG
  • Cook Medical LLC
  • Integer Holdings Corporation
  • Merit Medical Systems Inc
  • Penumbra Inc
  • Asahi Intecc Co Ltd
  • MicroVention Inc
  • Balt USA LLC
  • Imperative Care Inc
  • InNeuroCo Inc
  • Acandis GmbH & Co KG
  • Rapid Medical Ltd

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章前瞻性與潛力分析

第36章附錄

簡介目錄
Product Code: r18422

Neurovascular embolization devices are medical tools utilized to address irregular blood vessels in the brain or central nervous system by obstructing or altering blood flow. They play a crucial role in neuro-interventional treatments aimed at addressing conditions such as aneurysms, arteriovenous malformations (AVMs), and arteriovenous fistulas (AVFs) that could lead to bleeding or other adverse outcomes.

The primary products within the category of neurovascular embolization devices comprise embolization coils, liquid embolic systems, flow diversion stents, aneurysm clips, and other related items. Embolization coils, constructed from materials such as platinum or stainless steel, are flexible devices employed to block blood flow within vessels. They are utilized in diverse treatments such as ischemic and hemorrhagic stroke solutions and are indicated for conditions such as brain aneurysms and arteriovenous malformations. These devices are utilized by various end-users including hospitals, ambulatory surgical centers, and others.

The neurovascular embolization devices market research report is one of a series of new reports from The Business Research Company that provides neurovascular embolization devices market statistics, including the neurovascular embolization devices industry global market size, regional shares, competitors with neurovascular embolization devices market share, detailed neurovascular embolization devices market segments, market trends, and opportunities, and any further data you may need to thrive in the neurovascular embolization devices industry. These neurovascular embolization devices market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The neurovascular embolization devices market size has grown strongly in recent years. It will grow from $1.15 billion in 2023 to $1.23 billion in 2024 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to the rising geriatric population, the increased prevalence of neurovascular disorders, improved healthcare infrastructure, the demand for minimally invasive procedures, and increased healthcare expenditure.

The neurovascular embolization devices market size is expected to see strong growth in the next few years. It will grow to $1.60 billion in 2028 at a compound annual growth rate (CAGR) of 6.9%. The anticipated growth during the forecast period can be credited to the broadening utilization in emerging markets, the focus on patient-centered care, heightened awareness regarding neurovascular disorders, progressions in imaging technologies, and augmented investments in research and development. Key trends in the projected period encompass personalized treatment strategies, the incorporation of artificial intelligence into treatment planning, the introduction of next-generation embolic materials, a transition towards outpatient and ambulatory procedures, and the innovation of advanced embolization techniques.

The increasing incidence of hemorrhages is anticipated to drive the neurovascular embolization devices market forward. Hemorrhages represent abnormal and uncontrollable bleeding occurring either internally within the body or externally through breaks in the skin or mucous membranes. Factors contributing to the prevalence of hemorrhages include aging populations, heightened occurrences of hypertension, and expanded usage of anticoagulant medications. Neurovascular embolization devices play a crucial role in managing hemorrhagic strokes by blocking abnormal blood vessels, thereby reducing bleeding and averting further brain damage. For example, recent research conducted by King's College London indicates an expected 59.4% increase in cases and deaths from intracerebral hemorrhage (a specific type of hemorrhage) among individuals aged 70 to 95 across the UK by 2050. Consequently, the mounting prevalence of hemorrhages propels the growth of the neurovascular embolization devices market.

Major companies in the neurovascular embolization devices sector are concentrating on the development of technologically advanced products, such as shield technology, to address brain aneurysms and enhance their competitive position in the market. Shield Technology denotes an advanced attribute aimed at augmenting the effectiveness and safety of these devices while also contributing to their overall durability and longevity. For example, in June 2022, Medtronic PLC, an Ireland-based healthcare technology company, introduced the Pipeline Vantage with Shield Technology, a fourth-generation flow diverter in India. This device incorporates enhanced design features to enhance usability and reliability during endovascular procedures. By fostering cell growth in the blood vessel's inner lining, the device provides a scaffold that aids in the minimally invasive treatment of aneurysms, reduces the risk of rupture, and enhances patient outcomes.

In May 2023, Stryker Corporation, a US-based medical technology company, completed the acquisition of Cerus Endovascular Ltd for $530 million. This strategic move by Stryker was aimed at strengthening its expertise in offering innovative medical devices tailored for treating intracranial aneurysms, including products such as the contour neurovascular system and the neqstent coil-assisted flow diverter. Cerus Endovascular Ltd, headquartered in Ireland, specializes in the development of cutting-edge neurovascular embolization devices designed specifically for the treatment of intracranial aneurysms.

Major companies operating in the neurovascular embolization devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Heraeus Holding, Stryker Corporation, Boston Scientific Corporation, Kaneka Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical LLC, Integer Holdings Corporation, Merit Medical Systems Inc, Penumbra Inc, Asahi Intecc Co Ltd, MicroVention Inc, Balt USA LLC, Imperative Care Inc, InNeuroCo Inc, Acandis GmbH & Co KG, Rapid Medical Ltd, Emboline Inc, InspireMD Inc, QXMedical LLC, Vesalio LLC, EmbolX Inc

North America was the largest region in the neurovascular embolization devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurovascular embolization devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the neurovascular embolization devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The neurovascular embolization devices market consists of sales of particle embolic, detachable balloons, vascular plugs, and embolization microspheres. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neurovascular Embolization Devices Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neurovascular embolization devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neurovascular embolization devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The neurovascular embolization devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Embolization Coils; Liquid Embolic Systems; Flow Diversion Stents; Aneurysm Clips; Other Products
  • 2) By Treatment: Ischemic Stroke Solution; Hemorrhagic Stroke Solutions
  • 3) By Indication: Brain Aneurysms; Arteriovenous Malformation; Other Indications
  • 4) By End User: Hospitals; Ambulatory Surgical Centers; Other End Users
  • Companies Mentioned: Johnson & Johnson; Abbott Laboratories; Medtronic plc; Heraeus Holding; Stryker Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Neurovascular Embolization Devices Market Characteristics

3. Neurovascular Embolization Devices Market Trends And Strategies

4. Neurovascular Embolization Devices Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Neurovascular Embolization Devices Market Size and Growth

  • 5.1. Global Neurovascular Embolization Devices Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Neurovascular Embolization Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Neurovascular Embolization Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Neurovascular Embolization Devices Market Segmentation

  • 6.1. Global Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Embolization Coils
  • Liquid Embolic Systems
  • Flow Diversion Stents
  • Aneurysm Clips
  • Other Products
  • 6.2. Global Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Ischemic Stroke Solution
  • Hemorrhagic Stroke Solutions
  • 6.3. Global Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Brain Aneurysms
  • Arteriovenous Malformation
  • Other Indications
  • 6.4. Global Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Other End Users

7. Neurovascular Embolization Devices Market Regional And Country Analysis

  • 7.1. Global Neurovascular Embolization Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Neurovascular Embolization Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Neurovascular Embolization Devices Market

  • 8.1. Asia-Pacific Neurovascular Embolization Devices Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Neurovascular Embolization Devices Market

  • 9.1. China Neurovascular Embolization Devices Market Overview
  • 9.2. China Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Neurovascular Embolization Devices Market

  • 10.1. India Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Neurovascular Embolization Devices Market

  • 11.1. Japan Neurovascular Embolization Devices Market Overview
  • 11.2. Japan Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Neurovascular Embolization Devices Market

  • 12.1. Australia Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Neurovascular Embolization Devices Market

  • 13.1. Indonesia Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Neurovascular Embolization Devices Market

  • 14.1. South Korea Neurovascular Embolization Devices Market Overview
  • 14.2. South Korea Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Neurovascular Embolization Devices Market

  • 15.1. Western Europe Neurovascular Embolization Devices Market Overview
  • 15.2. Western Europe Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Neurovascular Embolization Devices Market

  • 16.1. UK Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Neurovascular Embolization Devices Market

  • 17.1. Germany Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Neurovascular Embolization Devices Market

  • 18.1. France Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Neurovascular Embolization Devices Market

  • 19.1. Italy Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Neurovascular Embolization Devices Market

  • 20.1. Spain Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Neurovascular Embolization Devices Market

  • 21.1. Eastern Europe Neurovascular Embolization Devices Market Overview
  • 21.2. Eastern Europe Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Neurovascular Embolization Devices Market

  • 22.1. Russia Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Neurovascular Embolization Devices Market

  • 23.1. North America Neurovascular Embolization Devices Market Overview
  • 23.2. North America Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Neurovascular Embolization Devices Market

  • 24.1. USA Neurovascular Embolization Devices Market Overview
  • 24.2. USA Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Neurovascular Embolization Devices Market

  • 25.1. Canada Neurovascular Embolization Devices Market Overview
  • 25.2. Canada Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Neurovascular Embolization Devices Market

  • 26.1. South America Neurovascular Embolization Devices Market Overview
  • 26.2. South America Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Neurovascular Embolization Devices Market

  • 27.1. Brazil Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Neurovascular Embolization Devices Market

  • 28.1. Middle East Neurovascular Embolization Devices Market Overview
  • 28.2. Middle East Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Neurovascular Embolization Devices Market

  • 29.1. Africa Neurovascular Embolization Devices Market Overview
  • 29.2. Africa Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Neurovascular Embolization Devices Market Competitive Landscape And Company Profiles

  • 30.1. Neurovascular Embolization Devices Market Competitive Landscape
  • 30.2. Neurovascular Embolization Devices Market Company Profiles
    • 30.2.1. Johnson & Johnson
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Abbott Laboratories
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Medtronic plc
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Heraeus Holding
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Stryker Corporation
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Neurovascular Embolization Devices Market Other Major And Innovative Companies

  • 31.1. Boston Scientific Corporation
  • 31.2. Kaneka Corporation
  • 31.3. Terumo Corporation
  • 31.4. B Braun Melsungen AG
  • 31.5. Cook Medical LLC
  • 31.6. Integer Holdings Corporation
  • 31.7. Merit Medical Systems Inc
  • 31.8. Penumbra Inc
  • 31.9. Asahi Intecc Co Ltd
  • 31.10. MicroVention Inc
  • 31.11. Balt USA LLC
  • 31.12. Imperative Care Inc
  • 31.13. InNeuroCo Inc
  • 31.14. Acandis GmbH & Co KG
  • 31.15. Rapid Medical Ltd

32. Global Neurovascular Embolization Devices Market Competitive Benchmarking

33. Global Neurovascular Embolization Devices Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Neurovascular Embolization Devices Market

35. Neurovascular Embolization Devices Market Future Outlook and Potential Analysis

  • 35.1 Neurovascular Embolization Devices Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Neurovascular Embolization Devices Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Neurovascular Embolization Devices Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer